July 1, 2020

As the prevalence of myopia grows throughout the world, the onset moves to younger ages, and higher levels are being seen in young adults, there is a developing consensus that treating myopia progression should have a goal of limiting the maximum level attained by an individual patient.

Our site uses cookies. By continuing to use this website, you agree to their use. For more details, please check our Privacy Policy.